Combine Mechanistic Modeling and DoE to Streamline QbD
BioPharm International-09-01-2010
Too many REMS cause headaches for doctors and the industry.
Use it label-free, or add labels to detect contaminants in solution.
What small biotechs need to know about quality management systems.
An in-depth analysis of the patent provisions of the new legislation.
The third holy grail of biosimilars: interchangeability.
How current economic conditions affect your build-or-buy decision.
Develop a relevant design space without full factorial DoE.
Advertisement
Advertisement
